These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16267284)

  • 1. Conditional depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis.
    Bhatt A; Kremer L; Dai AZ; Sacchettini JC; Jacobs WR
    J Bacteriol; 2005 Nov; 187(22):7596-606. PubMed ID: 16267284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis.
    Vilchèze C; Morbidoni HR; Weisbrod TR; Iwamoto H; Kuo M; Sacchettini JC; Jacobs WR
    J Bacteriol; 2000 Jul; 182(14):4059-67. PubMed ID: 10869086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis.
    Slayden RA; Barry CE
    Tuberculosis (Edinb); 2002; 82(4-5):149-60. PubMed ID: 12464486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.
    Schaeffer ML; Agnihotri G; Volker C; Kallender H; Brennan PJ; Lonsdale JT
    J Biol Chem; 2001 Dec; 276(50):47029-37. PubMed ID: 11600501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of InhA activity, but not KasA activity, induces formation of a KasA-containing complex in mycobacteria.
    Kremer L; Dover LG; Morbidoni HR; Vilchèze C; Maughan WN; Baulard A; Tu SC; Honoré N; Deretic V; Sacchettini JC; Locht C; Jacobs WR; Besra GS
    J Biol Chem; 2003 Jun; 278(23):20547-54. PubMed ID: 12654922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.
    Slayden RA; Lee RE; Barry CE
    Mol Microbiol; 2000 Nov; 38(3):514-25. PubMed ID: 11069675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platensimycin activity against mycobacterial beta-ketoacyl-ACP synthases.
    Brown AK; Taylor RC; Bhatt A; Fütterer K; Besra GS
    PLoS One; 2009 Jul; 4(7):e6306. PubMed ID: 19609444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function of heterologous Mycobacterium tuberculosis InhA, a type 2 fatty acid synthase enzyme involved in extending C20 fatty acids to C60-to-C90 mycolic acids, during de novo lipoic acid synthesis in Saccharomyces cerevisiae.
    Gurvitz A; Hiltunen JK; Kastaniotis AJ
    Appl Environ Microbiol; 2008 Aug; 74(16):5078-85. PubMed ID: 18552191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GroEL1: a dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria.
    Ojha A; Anand M; Bhatt A; Kremer L; Jacobs WR; Hatfull GF
    Cell; 2005 Dec; 123(5):861-73. PubMed ID: 16325580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biosynthesis of mycolic acids in Mycobacterium tuberculosis relies on multiple specialized elongation complexes interconnected by specific protein-protein interactions.
    Veyron-Churlet R; Bigot S; Guerrini O; Verdoux S; Malaga W; Daffé M; Zerbib D
    J Mol Biol; 2005 Nov; 353(4):847-58. PubMed ID: 16213523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a scintillation proximity assay for the Mycobacterium tuberculosis KasA and KasB enzymes involved in mycolic acid biosynthesis.
    Schaeffer ML; Carson JD; Kallender H; Lonsdale JT
    Tuberculosis (Edinb); 2004; 84(6):353-60. PubMed ID: 15525558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.
    Larsen MH; Vilchèze C; Kremer L; Besra GS; Parsons L; Salfinger M; Heifets L; Hazbon MH; Alland D; Sacchettini JC; Jacobs WR
    Mol Microbiol; 2002 Oct; 46(2):453-66. PubMed ID: 12406221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the dehydratase component of the mycobacterial mycolic acid-synthesizing fatty acid synthase-II complex.
    Brown AK; Bhatt A; Singh A; Saparia E; Evans AF; Besra GS
    Microbiology (Reading); 2007 Dec; 153(Pt 12):4166-4173. PubMed ID: 18048930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis.
    Kremer L; Dover LG; Carrère S; Nampoothiri KM; Lesjean S; Brown AK; Brennan PJ; Minnikin DE; Locht C; Besra GS
    Biochem J; 2002 Jun; 364(Pt 2):423-30. PubMed ID: 12023885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II.
    Marrakchi H; Lanéelle G; Quémard AK
    Microbiology (Reading); 2000 Feb; 146 ( Pt 2)():289-296. PubMed ID: 10708367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis.
    Kremer L; Douglas JD; Baulard AR; Morehouse C; Guy MR; Alland D; Dover LG; Lakey JH; Jacobs WR; Brennan PJ; Minnikin DE; Besra GS
    J Biol Chem; 2000 Jun; 275(22):16857-64. PubMed ID: 10747933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy.
    Gao LY; Laval F; Lawson EH; Groger RK; Woodruff A; Morisaki JH; Cox JS; Daffe M; Brown EJ
    Mol Microbiol; 2003 Sep; 49(6):1547-63. PubMed ID: 12950920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate recognition by β-ketoacyl-ACP synthases.
    Borgaro JG; Chang A; Machutta CA; Zhang X; Tonge PJ
    Biochemistry; 2011 Dec; 50(49):10678-86. PubMed ID: 22017312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III activity is inhibited by phosphorylation on a single threonine residue.
    Veyron-Churlet R; Molle V; Taylor RC; Brown AK; Besra GS; Zanella-Cléon I; Fütterer K; Kremer L
    J Biol Chem; 2009 Mar; 284(10):6414-24. PubMed ID: 19074144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The condensing activities of the Mycobacterium tuberculosis type II fatty acid synthase are differentially regulated by phosphorylation.
    Molle V; Brown AK; Besra GS; Cozzone AJ; Kremer L
    J Biol Chem; 2006 Oct; 281(40):30094-103. PubMed ID: 16873379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.